Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals



Status:Recruiting
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 18
Updated:12/19/2018
Start Date:November 1, 2018
End Date:April 1, 2020
Contact:Kaitlyn Mishlen, M.A.
Email:kaitlyn.mishlen@nyspi.columbia.edu
Phone:646-774-6174

Use our guide to learn which trials are right for you!

A short-term treatment with buprenorphine prior to initiating treatment with naltrexone may
increase the proportion of heroin-dependent patients successfully inducted onto Vivitrol.


Inclusion Criteria:

1. Individuals between the ages of 18-60

2. Meets DSM-5 criteria of current opioid use disorder with six consecutive months of
reported heroin use, supported by a positive urine for opiates indicating regular use
of heroin

3. Seeking treatment for opioid use disorder with Vivitrol

4. Capable of giving informed consent and complying with study procedures

5. In otherwise good health based on complete medical history and physical examination,
laboratory tests, and EKG

6. BMI between 18-40

Exclusion Criteria:

1. Reported treatment with methadone in the last 3 months or positive urine toxicology
for methadone on the day of consent

2. Maintenance on, or regular use of buprenorphine or other prescription opioids

3. Pregnancy, lactation, or failure in a sexually active woman to use adequate
contraceptive methods.

4. Active medical illness which might make participation hazardous, such as untreated
hypertension, acute hepatitis with AST or ALT > 3 times normal, AIDS (CD4 count under
200 currently or medically ill with an opportunistic infection), unstable diabetes,
cardiovascular disease.

5. Active psychiatric disorder which might interfere with participation or make
participation hazardous, including DSM-5 Schizophrenia or any psychotic disorder,
severe Major Depressive Disorder, or suicide risk or 1 or more suicide attempts within
the past year.

6. Physiologically dependent on alcohol or sedative- hypnotics with impending withdrawal.
Other substance use diagnoses are not exclusionary.

7. History of allergic or adverse reaction to buprenorphine, naltrexone, naloxone,
clonidine, or clonazepam.

8. Chronic neurocognitive disorder

9. History of accidental drug overdose in the last 3 years as defined as an episode of
opioid-induced unconsciousness or incapacitation, whether or not medical treatment was
sought or received.

10. Painful medical condition that requires ongoing opioid analgesia or anticipated
surgery necessitating opioid medications

11. Fentanyl only use, supported by a urine toxicology that is positive for fentanyl only
and negative for all other opioids.

12. Court mandated to treatment
We found this trial at
1
site
1051 Riverside Dr
New York, New York 10032
646-774-5000
Phone: 646-774-6174
New York State Psychiatric Institute The New York State Psychiatric Institute (NYSPI), established in 1895,...
?
mi
from
New York, NY
Click here to add this to my saved trials